# Ben Freeberg

> Ben Freeberg is a seed investor at Oncology Ventures (New York) backing Medical and Health Care. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Oncology Ventures](https://shizune.co/investors/profile/oncology-ventures)
- Location: New York, United States
- Total investments: 11
- Last investment: May 2026
- Lead investor: 27%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ben-freeberg-141a3043
- Website: https://x.com/oncoventures
- Facebook: https://www.facebook.com/ben.freeberg

Ben Freeberg is a seed investor at Oncology Ventures in New York focused on Medical and Health Care. Ben Freeberg is based out of New York and is the Founder and Managing Partner of Oncology Ventures. Ben previously worked at Thyme Care as an Advisor. Ben Freeberg attended Duke University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 36% |
| Health Care | 4 | 36% |
| Artificial Intelligence | 3 | 27% |
| Software | 2 | 18% |
| Biopharma | 2 | 18% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 36% |
| Series A | 3 | 27% |
| Venture - Series Unknown | 2 | 18% |
| Pre-Seed | 1 | 9% |
| Series B | 1 | 9% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 7 | 64% |
| Argentina | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Modicus Prime | Bringing Self-Service AI to the Life Sciences | $4.5M | Seed | May 06, 2026 |  |
| NexCure | NexCure offers clinically intense therapies in outpatient, community settings, revolutionizing the delivery, monitoring, and scaling of CAR-T and other cutting-edge treatments. | $19M | Series A | Mar 05, 2026 |  |
| CancerNavigator | CancerNavigator offers cancer navigation and analytics, connecting patients with care experts and providing personalized support. | $7M | Venture - Series Unknown | Feb 18, 2026 |  |
| RISA Labs | We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $11.1M | Series A | Jan 13, 2026 |  |
| BIOMAKERS | BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $8M | Series A | Jan 12, 2026 |  |
| Lumonus | Lumonous is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services. | $18.2M | Series B | Nov 06, 2025 |  |
| heva | heva is a vertical SaaS AI platform for doctors serving medical tourists. | $3.1M | Pre-Seed | Apr 25, 2025 |  |
| RISA Labs | We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $3.5M | Seed | Apr 17, 2025 |  |
| Daymark Health | Daymark Health is a cancer care company that focuses on providing in-home and virtual supportive care to cancer patients in collaboration with health plans. The company offers a wide range of supportive care services, including behavioral health care and social support, aimed at meeting the comprehensive needs of cancer patients. Daymark Healthconnects primary care physicians, oncologists, and other care teams to create a seamless and supportive experience for patients, leveraging both virtual and home-based care methodologies. | $11.5M | Seed | Apr 03, 2025 |  |
| mPath Health | DHN Solution is a cloud-based automation software platform that helps healthcare systems to improve their preventive care quality metrics. . | $1M | Seed | Oct 21, 2024 |  |

10 of 11 investments shown.

## Co-investors
- [Cencora Ventures](https://shizune.co/investors/profile/cencora-ventures) — VC Fund, 2 deals together
- [Collide Capital](https://shizune.co/investors/profile/collide-capital) — VC Fund, 2 deals together
- [z21 Ventures](https://shizune.co/investors/profile/z21-ventures) — VC Fund, 2 deals together
- [Acumen LatAm Impact Ventures](https://shizune.co/investors/profile/acumen-latam-capital-partners) — VC Fund, 1 deal together
- [Aviron Investment Management](https://shizune.co/investors/profile/aviron-investment-management) — VC Fund, 1 deal together
- [Benchstrength](https://shizune.co/investors/profile/benchstrength-fa17) — VC Fund, 1 deal together

## About Oncology Ventures

VC Fund · New York, United States

Oncology Ventures will make investments in cancer-focused data, infrastructure, IT, and services start-ups with the goal of fundamentally changing the way cancer treatment is conceived and provided at scale. Our fund will not invest in pharmaceuticals, therapies, or medical devices.

1 contacts available at Oncology Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Ben Freeberg | Founder and Managing Partner | https://shizune.co/investors/profile/ben-freeberg |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ben Freeberg invest in?

Ben Freeberg invests primarily in Medical, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ben Freeberg last invest?

The most recent investment recorded for Ben Freeberg closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co